Early systemic insults following traumatic brain injury: association with biomarker profiles, therapy for intracranial hypertension, and neurological outcomes—an analysis of CENTER-TBI data
Purpose We analysed the impact of early systemic insults (hypoxemia and hypotension, SIs) on brain injury biomarker profiles, acute care requirements during intensive care unit (ICU) stay, and 6-month outcomes in patients with traumatic brain injury (TBI). Methods From patients recruited to the Collaborative European neurotrauma effectiveness research in TBI (CENTER-TBI) study, we documented the prevalence and risk factors for SIs and analysed their effect on the levels of brain injury biomarkers [S100 calcium-binding protein B (S100B), neuron-specific enolase (NSE), neurofilament light (NfL), glial fibrillary acidic protein (GFAP), ubiquitin carboxy-terminal hydrolase L1 (UCH-L1), and protein Tau], critical care needs, and 6-month outcomes [Glasgow Outcome Scale Extended (GOSE)]. Results Among 1695 TBI patients, 24.5% had SIs: 16.1% had hypoxemia, 15.2% had hypotension, and 6.8% had both. Biomarkers differed by SI category, with higher S100B, Tau, UCH-L1, NSE and NfL values in patients with hypotension or both SIs. The ratio of neural to glial injury (quantified as UCH-L1/GFAP and Tau/GFAP ratios) was higher in patients with hypotension than in those with no SIs or hypoxia alone. At 6 months, 380 patients died (22%), and 759 (45%) had GOSE ≤ 4. Patients who experienced at least one SI had higher mortality than those who did not (31.8% vs. 19%, p < 0.001). Conclusion Though less frequent than previously described, SIs in TBI patients are associated with higher release of neuronal than glial injury biomarkers and with increased requirements for ICU therapies aimed at reducing intracranial hypertension. Hypotension or combined SIs are significantly associated with adverse 6-month outcomes. Current criteria for hypotension may lead to higher biomarker levels and more negative outcomes than those for hypoxemia suggesting a need to revisit pressure targets in the prehospital settings..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:50 |
|---|---|
| Enthalten in: |
Intensive care medicine - 50(2024), 3 vom: 20. Feb., Seite 371-384 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Robba, Chiara [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| BKL: | |
|---|---|
| Themen: |
Hypotension |
| Anmerkungen: |
© The Author(s) 2024 |
|---|
| doi: |
10.1007/s00134-024-07324-8 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
SPR055219799 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | SPR055219799 | ||
| 003 | DE-627 | ||
| 005 | 20240321064642.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240321s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s00134-024-07324-8 |2 doi | |
| 035 | |a (DE-627)SPR055219799 | ||
| 035 | |a (SPR)s00134-024-07324-8-e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q VZ |
| 084 | |a 44.69 |2 bkl | ||
| 100 | 1 | |a Robba, Chiara |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Early systemic insults following traumatic brain injury: association with biomarker profiles, therapy for intracranial hypertension, and neurological outcomes—an analysis of CENTER-TBI data |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a © The Author(s) 2024 | ||
| 520 | |a Purpose We analysed the impact of early systemic insults (hypoxemia and hypotension, SIs) on brain injury biomarker profiles, acute care requirements during intensive care unit (ICU) stay, and 6-month outcomes in patients with traumatic brain injury (TBI). Methods From patients recruited to the Collaborative European neurotrauma effectiveness research in TBI (CENTER-TBI) study, we documented the prevalence and risk factors for SIs and analysed their effect on the levels of brain injury biomarkers [S100 calcium-binding protein B (S100B), neuron-specific enolase (NSE), neurofilament light (NfL), glial fibrillary acidic protein (GFAP), ubiquitin carboxy-terminal hydrolase L1 (UCH-L1), and protein Tau], critical care needs, and 6-month outcomes [Glasgow Outcome Scale Extended (GOSE)]. Results Among 1695 TBI patients, 24.5% had SIs: 16.1% had hypoxemia, 15.2% had hypotension, and 6.8% had both. Biomarkers differed by SI category, with higher S100B, Tau, UCH-L1, NSE and NfL values in patients with hypotension or both SIs. The ratio of neural to glial injury (quantified as UCH-L1/GFAP and Tau/GFAP ratios) was higher in patients with hypotension than in those with no SIs or hypoxia alone. At 6 months, 380 patients died (22%), and 759 (45%) had GOSE ≤ 4. Patients who experienced at least one SI had higher mortality than those who did not (31.8% vs. 19%, p < 0.001). Conclusion Though less frequent than previously described, SIs in TBI patients are associated with higher release of neuronal than glial injury biomarkers and with increased requirements for ICU therapies aimed at reducing intracranial hypertension. Hypotension or combined SIs are significantly associated with adverse 6-month outcomes. Current criteria for hypotension may lead to higher biomarker levels and more negative outcomes than those for hypoxemia suggesting a need to revisit pressure targets in the prehospital settings. | ||
| 650 | 4 | |a Traumatic brain injury |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Serum biomarkers |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Outcome |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Hypoxemia |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Hypotension |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Systemic insults |7 (dpeaa)DE-He213 | |
| 700 | 1 | |a Graziano, Francesca |4 aut | |
| 700 | 1 | |a Picetti, Edoardo |4 aut | |
| 700 | 1 | |a Åkerlund, Cecilia |4 aut | |
| 700 | 1 | |a Addis, Alberto |4 aut | |
| 700 | 1 | |a Pastore, Giuseppe |4 aut | |
| 700 | 1 | |a Sivero, Mattia |4 aut | |
| 700 | 1 | |a Rebora, Paola |4 aut | |
| 700 | 1 | |a Galimberti, Stefania |4 aut | |
| 700 | 1 | |a Stocchetti, Nino |4 aut | |
| 700 | 1 | |a Maas, Andrew |4 aut | |
| 700 | 1 | |a Menon, David K. |4 aut | |
| 700 | 1 | |a Citerio, Giuseppe |0 (orcid)0000-0002-5374-3161 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Intensive care medicine |d Springer Berlin Heidelberg, 1975 |g 50(2024), 3 vom: 20. Feb., Seite 371-384 |w (DE-627)SPR001167375 |w (DE-600)1459201-0 |x 1432-1238 |7 nnns |
| 773 | 1 | 8 | |g volume:50 |g year:2024 |g number:3 |g day:20 |g month:02 |g pages:371-384 |
| 856 | 4 | 0 | |u https://dx.doi.org/10.1007/s00134-024-07324-8 |z kostenfrei |3 Volltext |
| 912 | |a GBV_SPRINGER | ||
| 912 | |a SSG-OLC-PHA | ||
| 936 | b | k | |a 44.69 |q VZ |
| 951 | |a AR | ||
| 952 | |d 50 |j 2024 |e 3 |b 20 |c 02 |h 371-384 | ||